D-1494-2022 Class II Terminated
FDA drug recall D-1494-2022 was initiated by Plastikon Healthcare LLC on Jun 7, 2022 and is designated Class II. Reason for recall: CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled. The recall status is terminated (terminated Jun 25, 2025). Affected quantity: 1,464 ampoules.
Recall details
- Product Type
- Drugs
- Report Date
- Sep 14, 2022
- Initiation Date
- Jun 7, 2022
- Termination Date
- Jun 25, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1,464 ampoules
Product description
CORRECTDOSE Children's COUGH & CHEST CONGESTION DM (Guaifenesin 100 mg / Dextromethorphan 5 mg per 5 mL) 2.04FL. OZ (60mL), packaged in 12-5 individual doses, Distributed by Correct Dose Inc, Braintree MA 02184. NDC 62320-321-05 UPC 8 60003 67146 7
Reason for recall
CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.
Distribution pattern
Distributed Nationwide in the USA
Code information
Lot # 21014A, EXP Feb. 2023
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1494-2022
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026